88IV - PR Newswire Asia's news - Medical/Pharmaceuticals


Ranok Therapeutics Announces the Publication of Positive Phase 1a Clinical Results for KRAS G12D Inhibitor RNK08954 in Cancer Discovery BOSTON and HANGZHOU, China , May 11, 2026 /PRNewswire/ -- Ranok Therapeutics, a clinical-stage biotechnology company developing innovative therapies, today announced the publication of preliminary ... 2026-05-11T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Leads Biolabs R&D Symposium: Platform Synergy and Multi-Mechanism Integration Reshape the Immuno-Oncology Landscape NANJING, China , May 11, 2026 /PRNewswire/ -- Nanjing Leads Biolabs Co., Ltd. ("Leads Biolabs"; Stock Code: 9887.HK) successfully held its R&D Symposium in Shanghai. Under the theme "Leads ... 2026-05-11T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Putting humanity back into the focus of 'technonatalism' in assisted reproduction BEIJING , May 11, 2026 /PRNewswire/ -- Since the world's first IVF baby was born almost 50 years ago, assisted reproductive technologies have advanced spectacularly to help millions of infertile ... 2026-05-11T Computer/Electronics Health Care/Hospital Medical Equipment Medical/Pharmaceuticals
Planning a Group Visit to Medtec Shanghai: A Corporate Buyer's Guide SHANGHAI , May 11, 2026 /PRNewswire/ -- Sourcing complex medical device components is rarely a solo job. Building a secure supply chain requires direct input from product engineering, quality control, ... 2026-05-11T Computer/Electronics Health Care/Hospital Medical Equipment Medical/Pharmaceuticals
Avalere Health expands to Japan with a full-service Advisory, Medical, and Marketing offering, led by industry veteran Junji Yokokawa Avalere Health Japan is designed with the full healthcare experience in mind, launching with an elite integrated team that brings together market access, medical, and marketing specialists, along with ... 2026-05-11T Health Care/Hospital Medical/Pharmaceuticals
ACROBiosystems Launches Global License Solution Upgrade for HEK293 Functional Cell Lines, Streamlining Compliance to Accelerate Biopharmaceutical R&D TOKYO , May 11, 2026 /PRNewswire/ -- ACROBiosystems announced a major upgrade to its global license solution for HEK293 functional cell lines. Centered on customer value and empowering global biopharmaceutical ... 2026-05-11T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
ACROBiosystems Launches Global License Solution Upgrade for HEK293 Functional Cell Lines, Streamlining Compliance to Accelerate Biopharmaceutical R&D SEOUL, South Korea , May 11, 2026 /PRNewswire/ -- ACROBiosystems announced a major upgrade to its global license solution for HEK293 functional cell lines. Centered on customer value and empowering global ... 2026-05-11T Biotechnology Health Care/Hospital Medical Equipment Medical/Pharmaceuticals
Study pinpoints 45 years as the critical threshold for a significant downturn in male fertility BEIJING , May 10, 2026 /PRNewswire/ -- Forty-five years has been identified as the critical age threshold at which elevated sperm DNA fragmentation significantly reduces fertility potential in men. ... 2026-05-10T Health Care/Hospital Medical/Pharmaceuticals Trade show news
ACROBiosystems Launches Global License Solution Upgrade for HEK293 Functional Cell Lines, Streamlining Compliance to Accelerate Biopharmaceutical R&D NEWARK, Del. , May 10, 2026 /PRNewswire/ -- ACROBiosystems has implemented a major upgrade to its global licensing framework for HEK293 functional cell lines, transitioning from a complex administrative ... 2026-05-10T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
South and East Asia identified as hotspots of global warming related impacts on male fertility BEIJING , May 9, 2026 /PRNewswire/ -- A major new study has shown that South and East Asia dominate patterns of global warming related decline in male fertility with the strongest and most consistent ... 2026-05-09T Computer/Electronics Health Care/Hospital Medical/Pharmaceuticals

PR Newswire Asia's news > Medical/Pharmaceuticals